Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Chronic Thromboembolic Pulmonary Hypertension in Hospitalized Patients: An Interprofessional Approach to Diagnosis, Pharmacologic Management, and Nursing Care

View through CrossRef
Background: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a rare but life-threatening condition classified as Group 4 pulmonary hypertension. It arises from persistent obstruction of the pulmonary arteries by organized thromboembolic material, leading to increased pulmonary vascular resistance, progressive pulmonary hypertension, and right heart failure. CTEPH is a potential sequela of acute pulmonary embolism, though a significant number of patients have no prior embolic history. Aim: This article synthesizes the essential knowledge for the diagnosis and management of CTEPH, emphasizing the critical need for a systematic, interprofessional approach to improve patient outcomes. It aims to outline the pathophysiological mechanisms, diagnostic pathway, and comprehensive treatment strategies. Methods: A stepwise diagnostic evaluation is recommended for at-risk patients, beginning with transthoracic echocardiography and utilizing ventilation-perfusion (V/Q) scanning as a highly sensitive screening tool. Confirmation requires right heart catheterization for hemodynamic assessment and imaging via computed tomography pulmonary angiography (CTPA) or pulmonary angiography to define the extent and accessibility of thromboembolic obstructions. Results: Pulmonary endarterectomy (PEA) is the cornerstone curative treatment for operable patients, significantly improving survival and hemodynamics. For inoperable cases or those with residual hypertension, balloon pulmonary angioplasty (BPA) and targeted medical therapy (notably the soluble guanylate cyclase stimulator riociguat) are effective alternatives. Lifelong anticoagulation is mandatory for all patients to prevent disease recurrence and progression. Conclusion: CTEPH is a complex disorder whose management hinges on early diagnosis within a specialized multidisciplinary team to determine the optimal treatment pathway among surgical, interventional, and medical options.
Title: Chronic Thromboembolic Pulmonary Hypertension in Hospitalized Patients: An Interprofessional Approach to Diagnosis, Pharmacologic Management, and Nursing Care
Description:
Background: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a rare but life-threatening condition classified as Group 4 pulmonary hypertension.
It arises from persistent obstruction of the pulmonary arteries by organized thromboembolic material, leading to increased pulmonary vascular resistance, progressive pulmonary hypertension, and right heart failure.
CTEPH is a potential sequela of acute pulmonary embolism, though a significant number of patients have no prior embolic history.
Aim: This article synthesizes the essential knowledge for the diagnosis and management of CTEPH, emphasizing the critical need for a systematic, interprofessional approach to improve patient outcomes.
It aims to outline the pathophysiological mechanisms, diagnostic pathway, and comprehensive treatment strategies.
Methods: A stepwise diagnostic evaluation is recommended for at-risk patients, beginning with transthoracic echocardiography and utilizing ventilation-perfusion (V/Q) scanning as a highly sensitive screening tool.
Confirmation requires right heart catheterization for hemodynamic assessment and imaging via computed tomography pulmonary angiography (CTPA) or pulmonary angiography to define the extent and accessibility of thromboembolic obstructions.
Results: Pulmonary endarterectomy (PEA) is the cornerstone curative treatment for operable patients, significantly improving survival and hemodynamics.
For inoperable cases or those with residual hypertension, balloon pulmonary angioplasty (BPA) and targeted medical therapy (notably the soluble guanylate cyclase stimulator riociguat) are effective alternatives.
Lifelong anticoagulation is mandatory for all patients to prevent disease recurrence and progression.
Conclusion: CTEPH is a complex disorder whose management hinges on early diagnosis within a specialized multidisciplinary team to determine the optimal treatment pathway among surgical, interventional, and medical options.

Related Results

Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Background: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are chronic diseases with a severe symptom burden. Common symptoms are dyspnoea at lig...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Interprofessional Collaboration as a Best Practice Across the Care Continuum
Interprofessional Collaboration as a Best Practice Across the Care Continuum
Purpose: Interprofessional teams are increasingly being recognized as a best practice for enhancing cooperation among multiple disciplines in delivering person-centered...
Chronic thromboembolic pulmonary hypertension: at the heart of the pulmonary arteries
Chronic thromboembolic pulmonary hypertension: at the heart of the pulmonary arteries
Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term consequence of acute pulmonary embolism (PE) and is frequently diagnosed at an advanced stage. It...

Back to Top